
Vitamin D3 and K2: is it worth combining them and how to dose (2026)
Vitamin D3 and K2: how much to take according to Polish guidelines 2023, where the evidence for combining ends, and why K2 requires a doctor's consent when taking warfarin.
Almost nine out of ten adult Poles have vitamin D levels below the optimal threshold in late winter and spring. The measurements included 5,775 people from 22 cities, so supplementation of cholecalciferol from autumn to spring is strongly justified in our case. However, a second thesis has emerged around it, repeated in product descriptions: that without vitamin K2, D3 alone directs calcium to the arteries instead of the bones. The biochemistry behind this reasoning is real, but studies on combined preparations are less impressive than advertising suggests. Below you will find what is actually known about both vitamins, what doses are recommended by Polish guidelines from 2023, and why K2 requires a conversation with a doctor when taking anticoagulants.
KEY INFORMATION
• 89.9% of adult Poles had 25(OH)D below 30 ng/ml (Płudowski et al., Pol Arch Med Wewn, 2016).
• Polish guidelines 2023: adults 1000-2000 IU D3 per day, after 75 years of age 2000-4000 IU.
• The upper limit set by EFSA for adults is 4000 IU per day.
• A two-year study of MK-7 with D3 did not slow down the calcification of the aortic valve.
• K2 weakens warfarin and acenocoumarol.
How does vitamin D3 work and why is it not enough for bones on its own?
Vitamin D3 increases calcium absorption from the intestines, but does not determine where that calcium will go. Two vitamin K-dependent proteins are responsible for the distribution: osteocalcin in bone and MGP in the vessel wall. Without vitamin K, both remain inactive and do not bind calcium.
Cholecalciferol is produced in the skin under the influence of UVB radiation or enters the body through food: fatty fish, eggs, and fortified products. In the liver, it is converted to 25(OH)D, the form measured in blood tests, and in the kidneys to calcitriol. Holick (New England Journal of Medicine, 2007) It has been described as a steroid hormone whose receptor acts in most human tissues.
The intestinal effect is the best documented: with balanced 25(OH)D levels, the body absorbs more calcium from the same meal than with a deficiency. Hence the rest of the reasoning. Since D3 increases the pool of available calcium, someone must ensure that it deposits in the bones and not in the artery walls.
This is where vitamin K comes in. Osteocalcin binds calcium in the bone matrix, MGP inhibits its deposition in blood vessels, and both proteins must first undergo carboxylation, for which vitamin K serves as a cofactor. Maresz (Integrative Medicine, 2015) He compiled this mechanism into a coherent argument, and this is what underlies the popularity of combined preparations. With one caveat that is not mentioned in advertisements: this is a description of biochemistry, not the result of a study on a finished product.
What does vitamin K2 do and which form actually works?
Vitamin K2 is a family of menaquinones designated by the symbol MK-n. In supplementation, only MK-7 really matters, as MK-4 in the doses found in food does not raise the level of vitamin K in the blood at all. The difference between the two forms is quantitative, but significant.
Sato, Schurgers i Uenishi (Nutrition Journal, 2012) They administered a single dose of 420 µg of MK-4 or MK-7 to healthy women, followed by 60 µg for a week. MK-7 was detectable in serum for up to 48 hours after ingestion, and after a week, it raised levels in all participants. MK-4 did not appear in serum at any measurement point, so its form from food does not affect vitamin K status.
Schurgers i in. (Blood, 2007) They compared MK-7 with synthetic vitamin K1. Both were well absorbed, but MK-7 has a significantly longer half-life, making its serum concentration more stable, and with prolonged intake, it increases seven to eightfold. MK-7 also carboxylated osteocalcin more fully.
MK-4 only works at pharmacological doses. In Japanese studies on osteoporosis, 45 mg was administered daily for two years (Shiraki i in., Journal of Bone and Mineral Research, 2000), which is about 250 times more than a typical dose of MK-7. When choosing a preparation, this is the only difference that really matters.
| Feature | MK-4 | MK-7 |
|---|---|---|
| Main source | animal products | natto i inne fermentacje |
| Detectability in serum after a dose of 420 µg | none at any measurement point | do 48 godzin |
| With continuous intake | the concentration does not increase | the concentration increases and stabilizes |
| Dose used in clinical studies | 45 mg per day | 180 µg per day |
Is the combination of D3 with K2 better than D3 alone?
There is no good evidence for that. The largest randomized trial of a combined preparation administered 720 µg of MK-7 with 25 µg of vitamin D to 365 men for two years and did not slow down aortic valve calcification compared to placebo (Diederichsen i in., Circulation, 2022).
The same trial included coronary arteries. Among 304 participants without ischemic disease, the calcification rate increased by 203 Agatston units in the treatment group and by 254 in the placebo group, and the difference was not statistically significant (Hasific i in., JACC: Advances, 2023). The benefit only appeared in the subgroup above 400 units, which the authors describe as a hypothesis to be tested.
Vitamin K2 alone, without D3, performs somewhat better. A meta-analysis of 14 studies involving 1,533 patients showed a slowdown in the progression of coronary calcifications (Li, Wang i Tu, Frontiers in Nutrition, 2023), and a two-year trial with 360 µg of MK-7 in patients with coronary disease favored the supplement (Vossen i in., JAMA Cardiology, 2026). However, a review of nine controlled studies summarized that vitamin K does not consistently inhibit the progression of calcifications, and a more pronounced effect is only seen in individuals with calcifications already at the start (Vlasschaert i in., Nutrients, 2020).
We noticed while organizing this data that it is worth reversing the question. If D3 without K2 calcified arteries, it would be evident in studies on vitamin D alone. Meanwhile, in the Women’s Health Initiative, women taking calcium with 400 IU of D3 for seven years had the same coronary calcification rate as the placebo group (Manson i in., Menopause, 2010). Encouraging numbers for K2 come from observational studies, such as the Rotterdam Study (Geleijnse i in., Journal of Nutrition, 2004), and these reasons do not provide evidence.
How much vitamin D3 and K2 should be taken daily according to Polish recommendations?
Polish guidelines from 2023 recommend that adults aged 19-65 take between 1000 to 2000 IU of cholecalciferol per day, and those over 75 years old should take between 2000 to 4000 IU throughout the year. For vitamin K2, there are no national recommendations, so supplement doses are based on research.
The document was prepared by a team of 34 authors under the editorship of Płudowski (Nutrients, 2023). According to him, a deficiency is defined as 25(OH)D below 20 ng/ml, the range of 20-30 ng/ml is suboptimal, and the target is 30-50 ng/ml. The dose is adjusted according to age and body weight, not to well-being. The maximum without medical supervision is 4000 IU for individuals with normal body weight and 10,000 IU for obesity, with the latter value pertaining to treatment.
For K2, the reference point is two studies by the same team. A dose of 180 µg over three years reduced the loss of spine and hip bone density in 244 postmenopausal women (Knapen i in., Osteoporosis International, 2013), and in the second analysis, it improved aortic compliance and halved the concentration of inactive MGP compared to placebo (Knapen i in., Thrombosis and Haemostasis, 2015). The range of 100-200 µg on labels is based on these studies, not on institutional recommendations.
When does vitamin D become dangerous?
When you chronically exceed the upper limit. EFSA has established the tolerable upper intake level for adults at 100 µg, or 4000 IU per day, based on persistent hypercalciuria. Above this threshold, supplementation ceases to be preventive and requires medical supervision.
The EFSA panel derived the limit from two human studies, where the lowest dose causing an adverse effect was 250 µg per day. An uncertainty factor of 2.5 was applied to this value, as a completely safe dose could not be identified. The limit applies to adults, including pregnant and breastfeeding women, as well as adolescents from the age of 11 (EFSA, 2023).
Vitamin D toxicity manifests as hypercalcemia. It begins nonspecifically, with weakness and loss of appetite, followed by increased thirst with polyuria, and if unrecognized, it leads to dehydration and kidney damage. Neither sunlight nor diet will cause it: skin synthesis has its own inhibitory mechanism. Only large doses from supplements or medications are responsible.
A practical rule is as follows: above 4000 IU per day, we are already talking about treating a deficiency, and treatment goes hand in hand with measuring 25(OH)D and calcium in serum before starting and after 3 to 4 months. Individuals with sarcoidosis, primary hyperparathyroidism, or calcium stones should determine their dose with a doctor regardless of its height, as hypercalcemia can occur at doses considered safe for them. You can find a comparison of upper limits for other ingredients in our przewodniku po limitach UL.
Who should not take K2 without a doctor's consent?
Anyone taking a vitamin K antagonist, such as warfarin or acenocoumarol. These medications work by blocking vitamin K, so its supplementation weakens their effect. Schurgers et al. warned that preparations providing 50 µg of MK-7 daily or more may significantly disrupt anticoagulant treatment.
This is the most serious interaction described in this article and the only one where a supplement taken without a doctor's knowledge can be genuinely dangerous. Warfarin and acenocoumarol inhibit the epoxide reductase of vitamin K, causing the factors dependent on it to remain inactive. Providing MK-7 externally partially bypasses this blockade: INR drops below the therapeutic range, increasing the risk of thrombosis. The threshold from the study Schurgersa i in. (Blood, 2007) is below half of what an average D3 capsule with K2 contains, so we are talking about completely ordinary doses.
However, this does not mean an absolute prohibition. A constant supply of vitamin K can be a stabilizing element for patients on anticoagulants, as fluctuations in intake are more harmful than a steady level. The decision is made by the attending physician, and after any dose change, INR monitoring is necessary.
Besides anticoagulants, be mindful of medications that affect vitamin D3 itself. Phenytoin and carbamazepine accelerate its metabolism, orlistat reduces the absorption of fats along with the vitamins dissolved in them, and steroid therapy increases calcium loss. The dose is then determined based on the 25(OH)D result, not by guesswork.
Who benefits the most from D3 supplementation with K2?
Individuals with documented vitamin D deficiency, of which there are many in Poland. In a study of 5,775 adults from 22 cities, 89.9% had 25(OH)D below 30 ng/ml, and 65.8% below 20 ng/ml, indicating a clear deficiency (Płudowski et al., Polish Archives of Internal Medicine, 2016).
Measurements were taken in late winter and spring of 2014, at the worst moment of the season. The average concentration was 18 ng/ml. Lower values were noted in men, younger individuals, and those with excessive body weight, which contradicts the belief that the problem mainly concerns seniors.
Wiek i tak pozostaje czynnikiem. MacLaughlin i Holick (Journal of Clinical Investigation, 1985) showed on skin samples that the ability to produce previtamin D3 decreases with age by more than half. Therefore, Polish guidelines provide individuals over 75 with a higher dose throughout the year, not just from September to May.
Another matter is magnesium. All enzymes metabolizing vitamin D require it as a cofactor, so with its deficiency, D3 supplementation is less effective (Uwitonze i Razzaque, Journal of the American Osteopathic Association, 2018). From our experience in assembling sets, magnesium has a stronger justification here than many trendy additional substances. We discuss the differences between its forms in a separate article about wyborze magnezu.
Frequently Asked Questions
Do you need to take K2 together with D3?
There is no hard clinical evidence for this. A two-year study with 720 µg of MK-7 and 25 µg of D3 in 365 men did not slow down the calcification of the aortic valve compared to placebo (Diederichsen i in., Circulation, 2022). The biochemical mechanism makes sense, and K2 in a reasonable dose is not harmful, but do not consider it a safety condition for D3.
How much vitamin D3 is safe to take daily without blood tests?
Up to 2000 IU for an adult with a normal body weight, according to Polish guidelines from 2023. The upper tolerable intake level according to EFSA is 100 µg, which is 4000 IU per day. Higher doses indicate treatment for deficiency and require testing for 25(OH)D and calcium in serum.
MK-7 or MK-4: which form of vitamin K2 makes sense?
MK-7. W badaniu Sato, Schurgersa i Uenishiego (Nutrition Journal, 2012) MK-4 administered at a dose of 420 µg was not detected in the serum of any participant, while MK-7 was detectable for up to 48 hours. MK-4 only works at doses around 45 mg, found in studies on osteoporosis, and not in supplements.
Is it permissible to combine K2 with warfarin or acenocoumarol?
Not without the consent of the attending physician. Schurgers et al. (Blood, 2007) warned that preparations providing 50 µg of MK-7 daily or more may significantly disrupt anticoagulant treatment. The supplement lowers INR and increases the risk of thrombosis, so any dose change requires laboratory monitoring.
How long does it take to see the effects of D3 supplementation?
It is advisable to check the concentration of 25(OH)D after 3 to 4 months of regular intake, as only then does it reflect the new dose. Bone effects are measured over years: Knapen i in. (Osteoporosis International, 2013) they noted a smaller loss of bone density only after three years of administering 180 µg of MK-7.
What should vitamin D3 be taken with to enhance absorption?
with the largest meal of the day. Mulligan i Licata (Journal of Bone and Mineral Research, 2010) they switched to this scheme for 17 patients treated without effect and achieved an average increase in 25(OH)D concentration of 56.7% without changing the dose. A regular lunch with fat is sufficient; there is no need to buy an oil preparation.
Is it necessary to check vitamin D levels before supplementation?
With a preventive dose of up to 2000 IU, it is not necessary. Testing for 25(OH)D becomes necessary when considering higher doses, experiencing deficiency symptoms, or having a disease affecting calcium metabolism. Polish guidelines from 2023 accept a range of 30-50 ng/ml as the target for adults.
If you are preparing a broader set for winter, check out our text on omega-3 dosing. Preparations with vitamin D3, K2, and magnesium can be found in the category supplements.
This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.
Author: Michał Waluk · Opublikowano: 2026-05-04 · Aktualizacja: 2026-08-07







